| NASDAQ (NMS) Exchange | US Country |
Aimei Health Technology Co., Ltd, established in 2023 and headquartered in New York, New York, is a company currently without significant operations. Its primary objective is to identify opportunities for mergers, share exchanges, asset acquisitions, share purchases, recapitalizations, reorganizations, or similar business combinations with one or more businesses or entities. Aimei Health Technology Co., Ltd is particularly focused on exploring opportunities within the biopharmaceutical, medical technology or device industries, as well as diagnostic services and other related sectors in the healthcare industry. This strategic approach indicates the company's intention to play a significant role in the dynamic and evolving healthcare sector by leveraging potential growth opportunities through acquisitions and partnerships.
As Aimei Health Technology Co., Ltd is in its initial stage of operation focusing on acquisitions and mergers, it does not currently offer specific products or services. However, the company has expressed its intent to target the following sectors for potential business combinations: